GT200200075A - NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS - Google Patents

NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS

Info

Publication number
GT200200075A
GT200200075A GT200200075A GT200200075A GT200200075A GT 200200075 A GT200200075 A GT 200200075A GT 200200075 A GT200200075 A GT 200200075A GT 200200075 A GT200200075 A GT 200200075A GT 200200075 A GT200200075 A GT 200200075A
Authority
GT
Guatemala
Prior art keywords
hcmv
patients
new
arilsulphonamids
antiviral agents
Prior art date
Application number
GT200200075A
Other languages
Spanish (es)
Inventor
Tobias Wunberg
Wolfang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Jorg Keldenich
Armin Kern
Siegfried Raddatz
Jurgen Reefschlager
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200200075A publication Critical patent/GT200200075A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS ARILSULFONAMIDAS DE FORMULA GENERAL (I) EN DONDE X,A,R1,R2,R3,R4, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS MUESTRAN UNA ACTIVIDAD ANTIVIRAL FRENTE A REPRESENTANTES DEL GRUPO DE HERPES VIRIDAE, ESPECIALMENTE FRENTE AL CITOMEGALOVIRUS HUMANO (HCMV) POR LO QUE SON UTILES EN LA PREVENCION Y ESTADOS INFECCIOSOS CAUSADOS POR HCMV EN PACIENTES CON SIDA, EN PACIENTES DE TRANSPLANTE DE MEDULA OSEA Y ORGANOS, EN RECIEN NACIDOS Y NIÑOS PEQUEÑOS, EN PACIENTES INMUNOSUPRIMIDOS POR CANCER, EN EMBARAZADAS POR INFECCION AGUDA CAUSADA POR HCMV.THE PRESENT INVENTION REFERS TO NEW ARILSULFONAMIDS OF GENERAL FORMULA (I) WHERE X, A, R1, R2, R3, R4, ARE FUNCTIONAL GROUPS DESCRIBED IN THE RECORD. THESE COMPOUNDS SHOW AN ANTIVIRAL ACTIVITY AGAINST REPRESENTATIVES OF THE HERPES VIRIDAE GROUP, ESPECIALLY AGAINST THE HUMAN CITOMEGALOVIRUS (HCMV), SO THAT THEY ARE USEFUL IN THE PREVENTION AND INFECTIVE STATES CAUSED BY HCMV IN PATIENTS WITH AIDS, IN PATIENTS ORGANS, IN NEWLY BORN AND SMALL CHILDREN, IN IMMUNE SUPPRESSED PATIENTS BY CANCER, IN PREGNANT BY ACUTE INFECTION CAUSED BY HCMV.

GT200200075A 2001-04-19 2002-04-18 NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS GT200200075A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19

Publications (1)

Publication Number Publication Date
GT200200075A true GT200200075A (en) 2002-12-24

Family

ID=7681939

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200200075A GT200200075A (en) 2001-04-19 2002-04-18 NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS

Country Status (9)

Country Link
KR (1) KR20030088509A (en)
AR (1) AR034309A1 (en)
CO (1) CO5540388A2 (en)
DE (1) DE10148598A1 (en)
EC (1) ECSP034813A (en)
GT (1) GT200200075A (en)
PE (1) PE20021061A1 (en)
SV (1) SV2003000995A (en)
ZA (1) ZA200307892B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
AU2003262831A1 (en) * 2002-08-23 2004-03-11 Rigel Pharmaceuticals, Inc. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
WO2004058253A1 (en) * 2002-12-18 2004-07-15 Cytovia, Inc. 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
DE10300109A1 (en) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Method for inhibiting replication of herpes viruses
EP1620412A2 (en) 2003-05-02 2006-02-01 Rigel Pharmaceuticals, Inc. Heterocyclic compounds and hydro isomers thereof
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US7410979B2 (en) 2003-11-19 2008-08-12 Rigel Pharmaceuticals, Inc. Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
US7514434B2 (en) 2004-02-23 2009-04-07 Rigel Pharmaceuticals, Inc. Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
CA2606106A1 (en) 2005-05-02 2007-03-08 Rigel Pharmaceuticals, Inc. Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (en) 2006-12-30 2008-07-31 Abbott Gmbh & Amp OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
ES2398676T3 (en) 2007-12-07 2013-03-20 Abbott Gmbh & Co. Kg Amidomethyl substituted oxindole derivatives and their use for the production of a drug for the treatment of vasopressin-dependent diseases
KR20100097195A (en) 2007-12-07 2010-09-02 애보트 게엠베하 운트 콤파니 카게 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
ES2455197T3 (en) 2007-12-07 2014-04-14 Abbvie Deutschland Gmbh & Co Kg 5,6-disubstituted oxindole derivatives and their use for the preparation of a medicine for the treatment of vasopressin-dependent diseases
US8703774B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
EP2435080A2 (en) 2009-05-29 2012-04-04 Abbott Laboratories Pharmaceutical compositions for the treatment of pain

Also Published As

Publication number Publication date
ZA200307892B (en) 2004-10-11
ECSP034813A (en) 2003-12-01
KR20030088509A (en) 2003-11-19
DE10148598A1 (en) 2002-10-24
AR034309A1 (en) 2004-02-18
SV2003000995A (en) 2003-03-18
PE20021061A1 (en) 2002-12-12
CO5540388A2 (en) 2005-07-29

Similar Documents

Publication Publication Date Title
GT200200075A (en) NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS
GT200200053A (en) NEW SPIROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASA-7
BR0214999A (en) Amide-substituted imidazopyridines
UY28500A1 (en) INHIBITORS OF SERINE PROTEASES, IN PARTICULAR PROTEASA NS3-NS4A HCV.
ECSP093601A (en) PROTEINS DERIVED FROM THE WHITE SPOT SYNDROME VIRUS AND ITS USES
DE69818094D1 (en) ANTIVIRAL CONNECTIONS
BRPI0411900A (en) antiviral compounds and methods
HN2002000317A (en) PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
CY1107200T1 (en) SUSPITUS SUSPENSION UNITS C
EA200500584A1 (en) NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY THE HEPATITIS C VIRUS
BRPI0411916A (en) sulfonamide-substituted imidazoquinolines
SG161315A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
HK1068538A1 (en) Antiviral compounds
UY29704A1 (en) MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS
BR0211962A (en) Combination of Enhanced Activity Immunostimulatory Oligonucleotide Parts
PE20030857A1 (en) COMPOUNDS AS INHIBITORS OF THE PROTEASE SERINE NS3 OF THE HEPATITIS C VIRUS
GT200300269A (en) NEW AROMATIC FLUOROGLUCOSID DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USES
DE60041210D1 (en) Oncolytic virus
NZ609146A (en) Modified 4’-nucleosides as antiviral agents
BR0116026A (en) Thioether-Replaced Imidazoquinolines
ECSP034568A (en) PIRIMIDIN 2,4,6-TRIONA TYPE METALOPROTEINASE INHIBITORS
TW200633995A (en) Andrographolide derivatives to treat viral infections
PA8573401A1 (en) INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM
AR037883A1 (en) BENZOFURANS 2-PHENYL SUBSTITUTED AS STROGEN AGENTS
HRP20050062B1 (en) Ciclesonide-containing sterile aqueous suspension